May 12, 2022 The Foundation in the News
Biopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
May 12, 2022
The national conference will be held on June 17–18, featuring sessions with the latest research advancements, practical adapting and thriving, and an opportunity to connect with the blind and low vision community.
May 10, 2022
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for retinal degenerative diseases, will host an online continuing medical education (CME and COPE) course on inherited retinal disease gene therapies on Thursday, June 9, 2022, at 7:00 p.m. EDT.
May 6, 2022
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, senior director scientific outreach, and often include conversations with guests from the research and vision communities.
Apr 22, 2022
The Foundation’s Investing in Cures Summit (ICS), held on April 2, 2022, in Half Moon Bay, California, convened 175 researchers, industry executives, and constituents to present and discuss the expanding and accelerating commercial development of emerging therapies for retinal degenerative diseases.
Mar 8, 2022
Trial recruitment is enabled by the Foundation Fighting Blindness’ patient registry, My Retina Tracker® Registry, which includes genetic and vision information for more than 20,000 people with inherited retinal diseases.
Mar 3, 2022
Industry Veteran Brings Broad Ophthalmology Research & Development Expertise.
Feb 23, 2022
The March 6th virtual event will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
Feb 2, 2022
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on January 27, 2022.
Jan 27, 2022
Commitment to expand translational research acceleration program and fund career development award.
Jan 19, 2022
Noteworthy Foundation executive increases role within organization.